JCCN (Vol 6, No 6) Now Available

The July issue of JNCCN – The Journal of the National Comprehensive Cancer Network (Volume 6, Number 6) is now available at http://www.nccn.org/JNCCN/default.asp and features:


NCCN Clinical Practice Guidelines in Oncology™
Cancer- and Chemotherapy-Induced Anemia

Anemia is a common condition in patients with cancer, but treating it is controversial. The new 2008 NCCN Guidelines include updates in response to the recently released FDA recommendations that limit use of erythropoiesis-stimulating agents in patients with cancer.

and Hodgkin Disease/Lymphoma

The past few decades have seen significant progress in the management of Hodgkin disease/lymphoma; in fact, cure rates have increased so extensively that the overriding treatment considerations often relate to long-term toxicity. The NCCN Guidelines discuss the clinical management of Hodgkin disease/lymphoma.

Other featured articles include:

Report on the NCCN 3rd Annual Patient Safety Summit
The issues of patient safety and preventing medical errors routinely make headlines, but the work currently ongoing to develop new safety systems and processes may be far less noticeable. This article summarizes the NCCN 3rd Annual Patient Safety Summit, which examined processes central to maintaining patient safety in the oncology setting: medication reconciliation, communication during patient hand-offs, and reporting of events, including “near-miss” events that do not reach a patient or result in harm. [CME]

Erythropoiesis-Stimulating Agents in Oncology

Establishing an Anemia Clinic for Optimal Erythropoietic-Stimulating Agent Use in Hematology-Oncology Patients

Intravenous Iron in Oncology [CME]

Role of PET/CT Scanning in Initial and Post-Treatment Assessment of Hodgkin Disease


Coming Soon!

The August issue of JNCCN includes:

NCCN Clinical Practice Guidelines in Oncology™
Head and Neck Cancers

Other featured articles:
Low Molecular Weight Heparins as Extended Prophylaxis Against Recurrent Thrombosis in Cancer Patients
By Cocav A. Engman, MD, and Leo R. Zacharski, MD

The Role of Inhibitors of the Epidermal Growth Factor in Management of Head and Neck Cancer
By Bruce Brockstein, MD; Mario Lacouture, MD; and Mark Agulnik, MD

Controversies in the Management of Oropharynx Cancer
By Francis P. Worden, MD, and Huan Ha, MD